One Stop Solution For In-Depth Market Research Reports
詳細な市場調査レポートのワンストップソリューション
SDKI (渋谷データ
カウント)
+ 81 3 45720790
sales@sdki.jp
Home > HEALTHCARE AND PHARMACEUTICALS > Immunoglobulins Market
Industries We Serve
当社が提供する産業
免疫グロブリン市場 - 世界の見通しと予測2021-2026
製品コード : ATHC00115219
調査 : Arizton
公開 : 14, June, 2022
カテゴリー : Healthcare and Pharmaceuticals
学習の場 : 北米（米国およびカナダ）、ラテンアメリカ（ブラジル、メキシコ、アルゼンチン、その他のラテンアメリカ）、ヨーロッパ（英国、ドイツ、フランス、イタリア、スペイン、ハンガリー、ベルギー、オランダおよびルクセンブルグ、NORDIC（フィンランド、スウェーデン、ノルウェー） 、デンマーク）、アイルランド、スイス、オーストリア、ポーランド、トルコ、ロシア、その他のヨーロッパ）、ポーランド、トルコ、ロシア、その他のヨーロッパ）、アジア太平洋（中国、インド、日本、韓国、シンガポール、インドネシア、マレーシア） 、オーストラリア、ニュージーランド、その他のアジア太平洋地域）、中東およびアフリカ（イスラエル、GCC（サウジアラビア、UAE、バーレーン、クウェート、カタール、オマーン）、北アフリカ、南アフリカ、その他の中東およびアフリカ）。
レポート形式 : PDF
販売価格オプション（消費税込み）
[レポートの説明]
COVID-19の影響に関する詳細な分析とデータ駆動型の洞察は、この世界免疫グロブリン市場レポートに含まれています
世界の免疫グロブリン市場は、2020年に135億9000万米ドルと評価され、2026年までに215億8000万米ドルに達し、予測期間中に8.01%のCAGRで成長すると予想されています
以下の要因が予測期間中の免疫グロブリン市場の成長に寄与する可能性が高い:
• 移植中のIVIgの使用の影響
• 血漿由来医薬品の自給自足プログラム
•ホームケアにおける分画プロセス、および免疫グロブリン
• 免疫グロブリンの最近の規制当局の承認
市場概要
パンデミックは、プラズマ誘導体業界に大きな影響を与えてきましたし、今後も大きな影響を与え続けています。これは、ドナー料金の増加と、収集量の減少に対するセンターの固定費の発生率の増加により、収集された血漿のコスト/リットルの増加に寄与した。最近の開発と、多数の希少疾患および自己免疫疾患の治療における免疫グロブリン製品の範囲の拡大により、免疫グロブリン産業の成長率が高まっています
主なハイライト
• 免疫グロブリンの価格は、ヨーロッパで約5%、米国で6%上昇しました
•分画の結果の増加と血漿不足の課題に伴い、血漿分画の分野における技術的および科学的発展は、免疫グロビンの市場を牽引することが期待されています.
•免疫グロブリンは、血漿由来製品の業界を支配しています。この割合は、主に自己免疫疾患の診断方法の開発による需要の増加に起因しています
• 免疫グロブリン業界にとっての大きな課題は、需要と供給のバランスを維持することです。免疫グロブリン産物は血漿を必要とするため、生産価値は採取された血漿の量によって制限される
•国の公式プラズマ収集機関とのパートナーシップは、多くのベンダーの成長を促進しました
この研究では、免疫グロブリン市場の現在のシナリオと、2020-2026年の期間の市場ダイナミクスを考慮しています。ここでは、いくつかの市場成長のイネーブラー、制約、トレンドの詳細な概要について説明します。このレポートは、市場の需要と供給の両方の側面を提供します。市場で事業を展開している大手企業やその他の著名な企業をプロファイルし、調査しています
セグメンテーション分析
•静脈内免疫グロブリン(IVIG)は、自己免疫疾患および免疫不全を管理するために最も使用される免疫グロブリンの形態である。免疫グロブリンの提案された治療的使用以来、それは静脈内経路を介して投与されており、これは最大の生物学的利用能および最大の有効性を提供する.
•市場は、2020年に世界の免疫グロブリン市場の26.05%を獲得した原発性免疫不全によってリードされています。原発性免疫不全の症状は、頻繁な肺炎、バロン感染症、副鼻腔感染症、皮膚感染症、髄膜炎、炎症、低血小板数などです
•エンドユーザーに基づく最大の免疫グロブリン市場シェアは、病院および診療所セグメントによって取得されます。在宅医療サービスの需要が高まっているため、在宅ケアセグメントはより速く成長すると予想されています
製品別セグメンテーション
• 静脈内免疫グロブリン
• 皮下免疫グロブリン
• 筋肉内免疫グロブリン
アプリケーション別セグメンテーション
• 原発性免疫不全
•慢性免疫不全多発性神経根尿症
• 二次免疫不全
•免疫血小板減少性紫斑病
• 重症筋無力症グラビス
• その他< >
エンドユーザー別
•病院&クリニック
• ホームケア
地理分析
• 北米は2020年に世界の免疫グロブリン市場の46.00%のシェアを獲得しました。これは、個人の健康に対する意識の高まり、患者中心の医療システム、医療の進歩、血漿収集センターのスループットの向上、業界固有の主要なグローバルベンダーなど、多くの要因に起因しています
•ヨーロッパは、他の地域と比較して需要が高いため、免疫グロブリン製品の2番目に大きな市場です。この地域は、意識が高く、規制の厳しい市場があり、安全な血液および血漿採取の実践を可能にしています
•APACは、自己免疫疾患の治療に必要な免疫グロブリン製品の新興産業と考えられています。中国はAPAC免疫グロブリン市場をリードしています。中国の人々は、献血と、命を救う製品の製造における献血の可能性に対する意識が高い
地理別
• 北米< >
o 米国< />
o カナダ< />
• ヨーロッパ
o ドイツ
o フランス< />
o イギリス< />
o イタリア< />
o スペイン< />
• APAC
o 中国
o 日本< />
o インド< />
o オーストラリア< />
o 韓国< />
• ラテンアメリカ
o ブラジル< />
o メキシコ< />
o アルゼンチン< />
• 中東・アフリカ
o 南アフリカ
o サウジアラビア
o トルコ
ベンダー分析
• 免疫グロブリン業界の主要プレーヤーは、武田薬品工業、CSLリミテッド、グリフォルス、S.A.、ケンドリオンバイオファーマ、オクタファルマAG.
•世界の免疫グロブリン業界は、主にCSLリミテッド、武田薬品工業株式会社、およびグリフォルスS.A.の3つのベンダーによって支配されています。彼らは非常に競争の激しい環境を共有しており、それぞれが新しい製品の発売とそれらと既存の製品の規制当局の承認に関して競争しています
• 新規ベンダーにとって、新興市場や低資源国は、人口が多く、補償として血液や血漿を寄付する傾向が強いため、理想的な市場です
主要ベンダー
• 武田薬品工業株式会社
• CSLリミテッド
•グリフォルス、SA < />
• ケンドリオン・バイオファーマ
• オクタファルマAG.
その他の著名なベンダー
• 中国生物製剤控股有限公司
• バイオテストAG
• LFB S.A.
• ADMA Biologics, Inc.
• オムリックスバイオファーマシューティカルズ株式会社
• ザイダス・カディラ
•バーラト血清ANdワクチンリミテッド
•リライアンスライフサイエンス
主な質問の回答:
1. 免疫グロブリン市場はどのくらいの大きさ?
2. 免疫グロブリン市場の主なトレンドは何ですか?
3. 免疫グロブリンの市場シェアが最も大きかったのはどの地域か?
4. 免疫グロブリン市場の主要プレーヤーは誰ですか?
5. 免疫グロブリン市場を牽引する要因は何ですか?
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 4 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 5 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 6 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 7 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 8 North America Immunoglobulins Market by End-user 2020–2026 (%)
Table 9 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 10 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 11 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 12 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 13 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 14 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 15 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 16 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 17 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 18 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 19 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 20 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 21 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 22 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 23 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 24 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 25 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 26 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 27 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 28 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 29 Middle East & Africa Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 30 Middle East & Africa Immunoglobulins Market by Application 2020–2026 (%)
Table 31 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 32 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 (%)
Table 33 Takeda Pharmaceutical Company Limited: Major Product Offerings
Table 34 CSL: Major Product Offerings
Table 35 Grifols, S.A.: Major Product Offerings
Table 36 Kendrion: Major Product Offerings
Table 37 Octapharma: Major Product Offerings
Table 38 China Biologic Products Holdings, Inc.: Major Product Offerings
Table 39 Biotest AG: Major Product Offerings
Table 40 LFB S.A.: Major Product Offerings
Table 41 ADMA Biologics, Inc.: Major Product Offerings
Table 42 Omrix Biopharmaceuticals LTD: Major Product Offerings
Table 43 Zydus Cadila: Major Product Offerings
Table 44 Bharat Serums and Vaccines Limited: Major Product Offerings
Table 45 Reliance Life Sciences: Major Product Offerings
Table 46 Global Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 47 Global Immunoglobulins Market by Product Type 2020–2026 (%)
Table 48 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 49 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 50 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 51 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 52 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 53 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 54 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 55 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 56 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 57 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 58 Global Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 59 Global Immunoglobulins Market by Application 2020–2026 (%)
Table 60 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 61 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 62 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 63 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 64 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 65 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 66 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 67 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 68 Middle East & Africa Immunoglobulins Market by Application 2020−2026 ($ billion)
Table 69 Middle East & Africa Immunoglobulins Market by Application 2020−2026 (%)
Table 70 Global Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 71 Global Immunoglobulins Market by End-user 2020–2026 (%)
Table 72 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 73 North America Immunoglobulins Market by End-user 2020−2026 (%)
Table 74 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 75 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 76 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 77 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 78 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 79 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 80 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 81 Middle East & Africa Immunoglobulins Market by End-User 2020–2026 (%)
Table 82 Global Immunoglobulins Market by Geography 2020–2026 ($ billion)
Table 83 Global Immunoglobulins Market by Geography 2020–2026 (%)
Table 84 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Table 85 Global Intravenous Immunoglobulins Market 2020–2026 (%)
Table 86 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Table 87 Global Subcutaneous Immunoglobulins Market 2020–2026 (%)
Table 88 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Table 89 Global Intramuscular Immunoglobulins Market 2020–2026 (%)
Table 90 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 91 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 92 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Table 93 Global CIDP Immunoglobulins Market 2020–2026 (%)
Table 94 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 95 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 96 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Table 97 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 (%)
Table 98 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Table 99 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 (%)
Table 100 Global Immunoglobulins Market by Others 2020–2026 ($ billion)
Table 101 Global Immunoglobulins Market by Others 2020–2026 (%)
Table 102 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Table 103 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 (%)
Table 104 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Table 105 Global Homecare Immunoglobulins Market 2020–2026 (%)
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 4 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 5 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 6 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 7 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 8 North America Immunoglobulins Market by End-user 2020–2026 (%)
Table 9 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 10 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 11 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 12 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 13 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 14 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 15 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 16 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 17 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 18 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 19 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 20 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 21 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 22 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 23 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 24 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 25 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 26 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 27 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 28 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 29 Middle East & Africa Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 30 Middle East & Africa Immunoglobulins Market by Application 2020–2026 (%)
Table 31 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 32 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 (%)
Table 33 Takeda Pharmaceutical Company Limited: Major Product Offerings
Table 34 CSL: Major Product Offerings
Table 35 Grifols, S.A.: Major Product Offerings
Table 36 Kendrion: Major Product Offerings
Table 37 Octapharma: Major Product Offerings
Table 38 China Biologic Products Holdings, Inc.: Major Product Offerings
Table 39 Biotest AG: Major Product Offerings
Table 40 LFB S.A.: Major Product Offerings
Table 41 ADMA Biologics, Inc.: Major Product Offerings
Table 42 Omrix Biopharmaceuticals LTD: Major Product Offerings
Table 43 Zydus Cadila: Major Product Offerings
Table 44 Bharat Serums and Vaccines Limited: Major Product Offerings
Table 45 Reliance Life Sciences: Major Product Offerings
Table 46 Global Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 47 Global Immunoglobulins Market by Product Type 2020–2026 (%)
Table 48 North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 49 North America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 50 Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 51 Europe Immunoglobulins Market by Product Type 2020–2026 (%)
Table 52 APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 53 APAC Immunoglobulins Market by Product Type 2020–2026 (%)
Table 54 Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 55 Latin America Immunoglobulins Market by Product Type 2020–2026 (%)
Table 56 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)
Table 57 Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)
Table 58 Global Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 59 Global Immunoglobulins Market by Application 2020–2026 (%)
Table 60 North America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 61 North America Immunoglobulins Market by Application 2020–2026 (%)
Table 62 Europe Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 63 Europe Immunoglobulins Market by Application 2020–2026 (%)
Table 64 APAC Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 65 APAC Immunoglobulins Market by Application 2020–2026 (%)
Table 66 Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)
Table 67 Latin America Immunoglobulins Market by Application 2020–2026 (%)
Table 68 Middle East & Africa Immunoglobulins Market by Application 2020−2026 ($ billion)
Table 69 Middle East & Africa Immunoglobulins Market by Application 2020−2026 (%)
Table 70 Global Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 71 Global Immunoglobulins Market by End-user 2020–2026 (%)
Table 72 North America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 73 North America Immunoglobulins Market by End-user 2020−2026 (%)
Table 74 Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 75 Europe Immunoglobulins Market by End-user 2020–2026 (%)
Table 76 APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 77 APAC Immunoglobulins Market by End-user 2020–2026 (%)
Table 78 Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 79 Latin America Immunoglobulins Market by End-user 2020–2026 (%)
Table 80 Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)
Table 81 Middle East & Africa Immunoglobulins Market by End-User 2020–2026 (%)
Table 82 Global Immunoglobulins Market by Geography 2020–2026 ($ billion)
Table 83 Global Immunoglobulins Market by Geography 2020–2026 (%)
Table 84 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Table 85 Global Intravenous Immunoglobulins Market 2020–2026 (%)
Table 86 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Table 87 Global Subcutaneous Immunoglobulins Market 2020–2026 (%)
Table 88 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Table 89 Global Intramuscular Immunoglobulins Market 2020–2026 (%)
Table 90 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 91 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 92 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Table 93 Global CIDP Immunoglobulins Market 2020–2026 (%)
Table 94 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Table 95 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 (%)
Table 96 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Table 97 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 (%)
Table 98 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Table 99 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 (%)
Table 100 Global Immunoglobulins Market by Others 2020–2026 ($ billion)
Table 101 Global Immunoglobulins Market by Others 2020–2026 (%)
Table 102 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Table 103 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 (%)
Table 104 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Table 105 Global Homecare Immunoglobulins Market 2020–2026 (%)
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Immunoglobulins Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Developments in Plasma Fractionation Process
Exhibit 4 Impact of Immunoglobulins in Homecare
Exhibit 5 Impact of Recent Regulatory Approvals for Immunoglobulin
Exhibit 6 Impact of Use of IVIg During Transplant
Exhibit 7 Self-sufficiency Programs for Plasma-derived Medicinal Products
Exhibit 8 Impact of IVIg-associated Hemolysis
Exhibit 9 Impact of Shortage of Immunoglobulin Products
Exhibit 10 Global Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 11 Global Immunoglobulins Market by Product Type
Exhibit 12 Global Immunoglobulins Market by Application
Exhibit 13 Global Immunoglobulins Market by End-user
Exhibit 14 Global Immunoglobulins Market by Geography
Exhibit 15 Five Forces Analysis 2020
Exhibit 16 Incremental Growth by Product Type 2020 & 2026
Exhibit 17 Global Immunoglobulins Market by Product Type
Exhibit 18 Global Immunoglobulins Market by Product Type: Incremental Growth 2020–2026 ($ billion)
Exhibit 19 Global Immunoglobulins Market by Product Type: Absolute Growth 2020–2026 (%)
Exhibit 20 Global Intravenous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 21 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 22 Incremental Growth by Geography 2020 & 2026
Exhibit 23 Global Subcutaneous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 24 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 25 Incremental Growth by Geography 2020 & 2026
Exhibit 26 Global Intramuscular Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 27 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 28 Incremental Growth by Geography 2020 & 2026
Exhibit 29 Incremental Growth by Segment 2020 & 2026
Exhibit 30 Global Immunoglobulins Market by Application
Exhibit 31 Global Immunoglobulins Market by Application: Incremental Growth 2020–2026 ($ billion)
Exhibit 32 Global Immunoglobulins Market by Application: Absolute Growth 2020–2026 ($ billion)
Exhibit 33 Global Primary Immunodeficiency Market: Incremental & Absolute Growth
Exhibit 34 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 35 Incremental Growth by Geography 2020 & 2026
Exhibit 36 Global CIDP Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 37 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 38 Incremental Growth by Geography 2020 & 2026
Exhibit 39 Global Secondary Immunodeficiency Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 40 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 41 Incremental Growth by Geography 2020 & 2026
Exhibit 42 Global Immune Thrombocytopenic Purpura Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 43 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 44 Incremental Growth by Geography 2020 & 2026
Exhibit 45 Global Myasthenia Gravis Immunoglobulins Market: Incremental Growth & Absolute Growth
Exhibit 46 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Geography 2020 & 2026
Exhibit 48 Global Immunoglobulins Market by Others: Incremental & Absolute Growth
Exhibit 49 Global Other Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 50 Incremental Growth by Geography 2020 & 2026
Exhibit 51 Incremental Growth by Application 2020 & 2026
Exhibit 52 Global Immunoglobulins Market by End-user
Exhibit 53 Global Immunoglobulins Market by End-user: Incremental Growth 2020–2026 ($ billion)
Exhibit 54 Global Immunoglobulins Market by End-user: Absolute Growth 2020–2026 (%)
Exhibit 55 Global Hospitals & Clinics Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 56 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 57 Incremental Growth by Geography 2020 & 2026
Exhibit 58 Global Homecare Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 59 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Incremental Growth by Geography 2020 & 2026
Exhibit 62 Global Immunoglobulins Market: Key Countries
Exhibit 63 Global Immunoglobulins Market by Geography: Incremental Growth 2020–2026 ($ billion)
Exhibit 64 Global Immunoglobulins Market by Geography: Absolute Growth 2020–2026 (%)
Exhibit 65 North America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 66 North America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 67 Incremental Growth by Product Type 2020 & 2026
Exhibit 68 Incremental Growth by Application 2020 & 2026
Exhibit 69 Incremental Growth by End-user 2020 & 2026
Exhibit 70 Incremental Growth in North America 2020 & 2026
Exhibit 71 Immunoglobulins Market in US 2020–2026 ($ billion)
Exhibit 72 Immunoglobulins Market in Canada 2020–2026 ($ billion)
Exhibit 73 Europe Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 74 Europe Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 75 Incremental Growth by Product Type 2020 & 2026
Exhibit 76 Incremental Growth by Application 2020 & 2026
Exhibit 77 Incremental Growth by End-user 2020 & 2026
Exhibit 78 Incremental Growth in Europe 2020 & 2026
Exhibit 79 Immunoglobulins Market in Germany 2020–2026 ($ billion)
Exhibit 80 Immunoglobulins Market in France 2020–2026 ($ billion)
Exhibit 81 Immunoglobulins Market in UK 2020–2026 ($ billion)
Exhibit 82 Immunoglobulins Market in Italy 2020–2026 ($ billion)
Exhibit 83 Immunoglobulins Market in Spain 2020–2026 ($ billion)
Exhibit 84 APAC Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 85 Immunoglobulins Market in APAC 2020–2026 ($ billion)
Exhibit 86 Incremental Growth by Product Type 2020 & 2026
Exhibit 87 Incremental Growth by Application 2020 & 2026
Exhibit 88 Incremental Growth by End-user 2020 & 2026
Exhibit 89 Incremental Growth in APAC 2020 & 2026
Exhibit 90 Immunoglobulins Market in China 2020–2026 ($ billion)
Exhibit 91 Immunoglobulins Market in Japan 2020–2026 ($ billion)
Exhibit 92 Immunoglobulins Market in India 2020–2026 ($ billion)
Exhibit 93 Immunoglobulins Market in Australia 2020–2026 ($ billion)
Exhibit 94 Immunoglobulins Market in South Korea 2020–2026 ($ billion)
Exhibit 95 Latin America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 96 Latin America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 97 Incremental Growth by Product Type 2020 & 2026
Exhibit 98 Incremental Growth by Application 2020 & 2026
Exhibit 99 Incremental Growth by End-user 2020 & 2026
Exhibit 100 Incremental Growth in Latin America 2020 & 2026
Exhibit 101 Immunoglobulins Market in Brazil 2020–2026 ($ billion)
Exhibit 102 Immunoglobulins Market in Mexico 2020–2026 ($ billion)
Exhibit 103 Immunoglobulins Market in Argentina 2020–2026 ($ billion)
Exhibit 104 Middle East & Africa Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 105 Middle East & Africa Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 106 Incremental Growth by Product Type 2020 & 2026
Exhibit 107 Incremental Growth by Application 2020 & 2026
Exhibit 108 Incremental Growth by End-user 2020 & 2026
Exhibit 109 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 110 Immunoglobulins Market in South Africa 2020–2026 ($ billion)
Exhibit 111 Immunoglobulins Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 112 Immunoglobulins Market in Turkey 2020–2026 ($ billion)
Exhibit 113 Global Immunoglobulins Market: Vendor Market Share (2020)
Exhibit 114 Takeda Pharmaceutical Company Limited: Total Revenue 2018−2020 ($ billion)
Exhibit 115 Takeda Pharmaceutical Company Limited: Total Revenue by Geography 2019 & 2020 ($ billion)
Exhibit 116 Takeda Pharmaceutical Company Limited: R&D Expenditure 2018−2020 ($ billion)
Exhibit 117 Takeda Pharmaceutical Company Limited: Total Revenue by Immunoglobin 2018−2020 ($ billion)
Exhibit 118 CSL Limited: Total Revenue 2018−2020 ($ million)
Exhibit 119 CSL Limited: R&D Expenditure 2018−2020 ($ million)
Exhibit 120 Grifols, S.A.: Total Revenue 2018−2020 ($ million)
Exhibit 121 Grifols, S.A.: R&D Expenditure 2018−2020 ($ million)
Exhibit 122 Kendrion: Total Revenue 2018−2020 ($ million)
Exhibit 123 Kendrion: R&D Expenditure 2018−2020 ($ million)
Exhibit 124 Octapharma AG: Total Revenue 2018−2020 ($ million)
Exhibit 125 Octapharma AG: R&D Expenditure 2018−2020 ($ million)
Exhibit 1 Segmentation of Global Immunoglobulins Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Developments in Plasma Fractionation Process
Exhibit 4 Impact of Immunoglobulins in Homecare
Exhibit 5 Impact of Recent Regulatory Approvals for Immunoglobulin
Exhibit 6 Impact of Use of IVIg During Transplant
Exhibit 7 Self-sufficiency Programs for Plasma-derived Medicinal Products
Exhibit 8 Impact of IVIg-associated Hemolysis
Exhibit 9 Impact of Shortage of Immunoglobulin Products
Exhibit 10 Global Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 11 Global Immunoglobulins Market by Product Type
Exhibit 12 Global Immunoglobulins Market by Application
Exhibit 13 Global Immunoglobulins Market by End-user
Exhibit 14 Global Immunoglobulins Market by Geography
Exhibit 15 Five Forces Analysis 2020
Exhibit 16 Incremental Growth by Product Type 2020 & 2026
Exhibit 17 Global Immunoglobulins Market by Product Type
Exhibit 18 Global Immunoglobulins Market by Product Type: Incremental Growth 2020–2026 ($ billion)
Exhibit 19 Global Immunoglobulins Market by Product Type: Absolute Growth 2020–2026 (%)
Exhibit 20 Global Intravenous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 21 Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 22 Incremental Growth by Geography 2020 & 2026
Exhibit 23 Global Subcutaneous Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 24 Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 25 Incremental Growth by Geography 2020 & 2026
Exhibit 26 Global Intramuscular Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 27 Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 28 Incremental Growth by Geography 2020 & 2026
Exhibit 29 Incremental Growth by Segment 2020 & 2026
Exhibit 30 Global Immunoglobulins Market by Application
Exhibit 31 Global Immunoglobulins Market by Application: Incremental Growth 2020–2026 ($ billion)
Exhibit 32 Global Immunoglobulins Market by Application: Absolute Growth 2020–2026 ($ billion)
Exhibit 33 Global Primary Immunodeficiency Market: Incremental & Absolute Growth
Exhibit 34 Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 35 Incremental Growth by Geography 2020 & 2026
Exhibit 36 Global CIDP Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 37 Global CIDP Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 38 Incremental Growth by Geography 2020 & 2026
Exhibit 39 Global Secondary Immunodeficiency Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 40 Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 41 Incremental Growth by Geography 2020 & 2026
Exhibit 42 Global Immune Thrombocytopenic Purpura Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 43 Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 44 Incremental Growth by Geography 2020 & 2026
Exhibit 45 Global Myasthenia Gravis Immunoglobulins Market: Incremental Growth & Absolute Growth
Exhibit 46 Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Geography 2020 & 2026
Exhibit 48 Global Immunoglobulins Market by Others: Incremental & Absolute Growth
Exhibit 49 Global Other Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 50 Incremental Growth by Geography 2020 & 2026
Exhibit 51 Incremental Growth by Application 2020 & 2026
Exhibit 52 Global Immunoglobulins Market by End-user
Exhibit 53 Global Immunoglobulins Market by End-user: Incremental Growth 2020–2026 ($ billion)
Exhibit 54 Global Immunoglobulins Market by End-user: Absolute Growth 2020–2026 (%)
Exhibit 55 Global Hospitals & Clinics Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 56 Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 57 Incremental Growth by Geography 2020 & 2026
Exhibit 58 Global Homecare Immunoglobulins Market: Incremental & Absolute Growth
Exhibit 59 Global Homecare Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Incremental Growth by Geography 2020 & 2026
Exhibit 62 Global Immunoglobulins Market: Key Countries
Exhibit 63 Global Immunoglobulins Market by Geography: Incremental Growth 2020–2026 ($ billion)
Exhibit 64 Global Immunoglobulins Market by Geography: Absolute Growth 2020–2026 (%)
Exhibit 65 North America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 66 North America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 67 Incremental Growth by Product Type 2020 & 2026
Exhibit 68 Incremental Growth by Application 2020 & 2026
Exhibit 69 Incremental Growth by End-user 2020 & 2026
Exhibit 70 Incremental Growth in North America 2020 & 2026
Exhibit 71 Immunoglobulins Market in US 2020–2026 ($ billion)
Exhibit 72 Immunoglobulins Market in Canada 2020–2026 ($ billion)
Exhibit 73 Europe Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 74 Europe Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 75 Incremental Growth by Product Type 2020 & 2026
Exhibit 76 Incremental Growth by Application 2020 & 2026
Exhibit 77 Incremental Growth by End-user 2020 & 2026
Exhibit 78 Incremental Growth in Europe 2020 & 2026
Exhibit 79 Immunoglobulins Market in Germany 2020–2026 ($ billion)
Exhibit 80 Immunoglobulins Market in France 2020–2026 ($ billion)
Exhibit 81 Immunoglobulins Market in UK 2020–2026 ($ billion)
Exhibit 82 Immunoglobulins Market in Italy 2020–2026 ($ billion)
Exhibit 83 Immunoglobulins Market in Spain 2020–2026 ($ billion)
Exhibit 84 APAC Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 85 Immunoglobulins Market in APAC 2020–2026 ($ billion)
Exhibit 86 Incremental Growth by Product Type 2020 & 2026
Exhibit 87 Incremental Growth by Application 2020 & 2026
Exhibit 88 Incremental Growth by End-user 2020 & 2026
Exhibit 89 Incremental Growth in APAC 2020 & 2026
Exhibit 90 Immunoglobulins Market in China 2020–2026 ($ billion)
Exhibit 91 Immunoglobulins Market in Japan 2020–2026 ($ billion)
Exhibit 92 Immunoglobulins Market in India 2020–2026 ($ billion)
Exhibit 93 Immunoglobulins Market in Australia 2020–2026 ($ billion)
Exhibit 94 Immunoglobulins Market in South Korea 2020–2026 ($ billion)
Exhibit 95 Latin America Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 96 Latin America Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 97 Incremental Growth by Product Type 2020 & 2026
Exhibit 98 Incremental Growth by Application 2020 & 2026
Exhibit 99 Incremental Growth by End-user 2020 & 2026
Exhibit 100 Incremental Growth in Latin America 2020 & 2026
Exhibit 101 Immunoglobulins Market in Brazil 2020–2026 ($ billion)
Exhibit 102 Immunoglobulins Market in Mexico 2020–2026 ($ billion)
Exhibit 103 Immunoglobulins Market in Argentina 2020–2026 ($ billion)
Exhibit 104 Middle East & Africa Immunoglobulins Market: Key Countries 2020 ($ billion)
Exhibit 105 Middle East & Africa Immunoglobulins Market 2020–2026 ($ billion)
Exhibit 106 Incremental Growth by Product Type 2020 & 2026
Exhibit 107 Incremental Growth by Application 2020 & 2026
Exhibit 108 Incremental Growth by End-user 2020 & 2026
Exhibit 109 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 110 Immunoglobulins Market in South Africa 2020–2026 ($ billion)
Exhibit 111 Immunoglobulins Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 112 Immunoglobulins Market in Turkey 2020–2026 ($ billion)
Exhibit 113 Global Immunoglobulins Market: Vendor Market Share (2020)
Exhibit 114 Takeda Pharmaceutical Company Limited: Total Revenue 2018−2020 ($ billion)
Exhibit 115 Takeda Pharmaceutical Company Limited: Total Revenue by Geography 2019 & 2020 ($ billion)
Exhibit 116 Takeda Pharmaceutical Company Limited: R&D Expenditure 2018−2020 ($ billion)
Exhibit 117 Takeda Pharmaceutical Company Limited: Total Revenue by Immunoglobin 2018−2020 ($ billion)
Exhibit 118 CSL Limited: Total Revenue 2018−2020 ($ million)
Exhibit 119 CSL Limited: R&D Expenditure 2018−2020 ($ million)
Exhibit 120 Grifols, S.A.: Total Revenue 2018−2020 ($ million)
Exhibit 121 Grifols, S.A.: R&D Expenditure 2018−2020 ($ million)
Exhibit 122 Kendrion: Total Revenue 2018−2020 ($ million)
Exhibit 123 Kendrion: R&D Expenditure 2018−2020 ($ million)
Exhibit 124 Octapharma AG: Total Revenue 2018−2020 ($ million)
Exhibit 125 Octapharma AG: R&D Expenditure 2018−2020 ($ million)
SDKI
×